Vulnerabilities

Vulnerability · CVE-2026-56317

Nuxt before 4.4.7 (and the 3.x branch before 3.21.7) contains a cross-site scripting vulnerability in the NoScript component that writes slot content to innerHTML without escaping.

Published Jun 20, 2026 · catalog updated Jun 24, 2026 · Nuxt before 4.4.7 (and

Last checked Nov 11, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2026-56317. EPSS is 0.34%. Act only if a listed version of Nuxt before 4.4.7 (and is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Nuxt before 4.4.7 (and).
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Low2.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.34%
Remediation
Version ranges on file
Affected products
cpe nuxt/nuxt

Nuxt before 4.4.7 (and the 3.x branch before 3.21.7) contains a cross-site scripting vulnerability in the NoScript component that writes slot content to innerHTML without escaping. Attackers can inject malicious scripts through untrusted data in NoScript slots, such as route.query parameters, which execute in the document context when the noscript tag is implicitly closed by script tags.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe nuxt/nuxt< 3.21.7
  • cpe nuxt/nuxt< 4.4.7

How to fix CVE-2026-56317

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-56317. EPSS is 0.34%. Act only if a listed version of Nuxt before 4.4.7 (and is installed.

Which versions are affected?

Compare what you have installed with < 3.21.7, < 4.4.7. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.34%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Jun 20, 2026 · Monitored products — high

    Detected

    Nuxt before 4.4.7 (and the 3.x branch before 3.21.7) contains a cross-site scripting vulnerability in the NoScript component that writes slot content to innerHTML without escaping. Attackers can inject malicious scripts through untrusted data in NoScript slots, such as route.query parameters, which execute in the document context when the noscript tag is implicitly closed by script tags.

  2. Jun 24, 2026 · Monitored products — high

    Updated

    Nuxt before 4.4.7 (and the 3.x branch before 3.21.7) contains a cross-site scripting vulnerability in the NoScript component that writes slot content to innerHTML without escaping. Attackers can inject malicious scripts through untrusted data in NoScript slots, such as route.query parameters, which execute in the document context when the noscript tag is implicitly closed by script tags.

Sources

  • CVE.orgVulnerability recordCVE-2026-56317

    Official CVE identifier

    cve.org
  • Monitored products — highVendor advisoryCVE-2026-56317

    Nuxt before 4.4.7 (and the 3.x branch before 3.21.7) contains a cross-site scripting vulnerability in the NoScript component that writes slot content to innerHTML without escaping. Attackers can inject malicious scripts through untrusted data in NoScript slots, such as route.query parameters, which execute in the document context when the noscript tag is implicitly closed by script tags.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Nov 11, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgNov 8, 2026
  • Monitored products — highNov 8, 2026